In chemistry, an ionophore (from Greek ion and -phore 'ion carrier') is a chemical species that reversibly binds ions.[1] Many ionophores are lipid-soluble entities that transport ions across the cell membrane. Ionophores catalyze ion transport across hydrophobic membranes, such as liquid polymeric membranes (carrier-based ion selective electrodes) or lipid bilayers found in the living cells or synthetic vesicles (liposomes).[1] Structurally, an ionophore contains a hydrophilic center and a hydrophobic portion that interacts with the membrane.
Some ionophores are synthesized by microorganisms to import ions into their cells. Synthetic ion carriers have also been prepared. Ionophores selective for cations and anions have found many applications in analysis.[2] These compounds have also shown to have various biological effects and a synergistic effect when combined with the ion they bind.[3]
Classification
Biological activities of metal ion-binding compounds can be changed in response to the increment of the metal concentration, and based on the latter compounds can be classified as "metal ionophores", "metal chelators" or "metal shuttles".[3] If the biological effect is augmented by increasing the metal concentration, it is classified as a "metal ionophore". If the biological effect is decreased or reversed by increasing the metal concentration, it is classified as a "metal chelator". If the biological effect is not affected by increasing the metal concentration, and the compound-metal complex enters the cell, it is classified as a "metal shuttle". The term ionophore (from Greekion carrier or ion bearer) was proposed by Berton Pressman in 1967 when he and his colleagues were investigating the antibiotic mechanisms of valinomycin and nigericin.[4]
Many ionophores are produced naturally by a variety of microbes, fungi and plants, and act as a defense against competing or pathogenic species. Multiple synthetic membrane-spanning ionophores have also been synthesized.[5]
The two broad classifications of ionophores synthesized by microorganisms are:
Carrier ionophores that bind to a particular ion and shield its charge from the surrounding environment. This makes it easier for the ion to pass through the hydrophobic interior of the lipid membrane.[6] However, these ionophores become unable to transport ions under very low temperatures.[7] An example of a carrier ionophore is valinomycin, a molecule that transports a single potassiumcation. Carrier ionophores may be proteins or other molecules.
Channel formers that introduce a hydrophilic pore into the membrane, allowing ions to pass through without coming into contact with the membrane's hydrophobic interior.[8] Channel forming ionophores are usually large proteins. This type of ionophores can maintain their ability to transfer ions at low temperatures, unlike carrier ionophores.[7] Examples of channel-forming ionophores are gramicidin A and nystatin.
Ionophores that transport hydrogen ions (H+, i.e. protons) across the cell membrane are called protonophores. Iron ionophores and chelating agents are collectively called siderophores.
Synthetic ionophores
Many synthetic ionophores are based on crown ethers, cryptands, and calixarenes. Pyrazole-pyridine and bis-pyrazole derivatives have also been synthesized.[9] These synthetic species are often macrocyclic.[10] Some synthetic agents are not macrocyclic, e.g. carbonyl cyanide-p-trifluoromethoxyphenylhydrazone. Even simple organic compounds, such as phenols, exhibit ionophoric properties. The majority of synthetic receptors used in the carrier-based anion-selective electrodes employ transition elements or metalloids as anion carriers, although simple organic urea- and thiourea-based receptors are known.[11]
Mechanism of action
Ionophores are chemical compounds that reversibly bind and transport ions through biological membranes in the absence of a protein pore. This can disrupt the membrane potential, and thus these substances could exhibit cytotoxic properties.[1] Ionophores modify the permeability of biological membranes toward certain ions to which they show affinity and selectivity. Many ionophores are lipid-soluble and transport ions across hydrophobic membranes, such as lipid bilayers found in the living cells or synthetic vesicles (liposomes), or liquid polymeric membranes (carrier-based ion selective electrodes).[1] Structurally, an ionophore contains a hydrophilic center and a hydrophobic portion that interacts with the membrane. Ions are bound to the hydrophilic center and form an ionophore-ion complex. The structure of the ionophore-ion complex has been verified by X-ray crystallography.[12]
Chemistry
Several chemical factors affect the ionophore activity.[13] The activity of an ionophore-metal complex depends on its geometric configuration and the coordinating sites and atoms which create coordination environment surrounding the metal center. This affects the selectivity and affinity towards a certain ion. Ionophores can be selective to a particular ion but may not be exclusive to it. Ionophores facilitate the transport of ions across biological membranes most commonly via passive transport, which is affected by lipophilicity of the ionophore molecule. The increase in lipophilicity of the ionophore-metal complex enhances its permeability through lipophilic membranes. The hydrophobicity and hydrophilicity of the complex also determines whether it will slow down or ease the transport of metal ions into cell compartments. The reduction potential of a metal complex influences its thermodynamic stability and affects its reactivity. The ability of an ionophore to transfer ions is also affected by the temperature.
Biological properties
Ionophores are widely used in cell physiology experiments and biotechnology as these compounds can effectively perturb gradients of ions across biological membranes and thus they can modulate or enhance the role of key ions in the cell.[14] Many ionophores have shown antibacterial and antifungal activities.[15] Some of them also act against insects, pests and parasites. Some ionophores have been introduced into medicinal products for dermatological and veterinary use.[16][17] A large amount of research has been directed toward investigating novel antiviral, anti-inflammatory, anti-tumor, antioxidant and neuroprotective properties of different ionophores.[15][18][3]
Polyene antimycotics, such as nystatin, natamycin and amphotericin B, are a subgroup of macrolides and are widely used antifungal and antileishmanial medications. These drugs act as ionophores by binding to ergosterol in the fungal cell membrane and making it leaky and permeable for K+ and Na+ ions, as a result contributing to fungal cell death.[32]
^Rodríguez-Vázquez, Nuria; Fuertes, Alberto; Amorín, Manuel; Granja, Juan R. (2016). "Chapter 14. Bioinspired Artificial Sodium and Potassium Ion Channels". In Astrid, Sigel; Helmut, Sigel; Roland K.O., Sigel (eds.). The Alkali Metal Ions: Their Role in Life. Metal Ions in Life Sciences. Vol. 16. Springer. pp. 485–556. doi:10.1007/978-3-319-21756-7_14. ISBN978-3-319-21755-0. PMID26860310.
^Tardito, Saverio; Bassanetti, Irene; Bignardi, Chiara; Elviri, Lisa; Tegoni, Matteo; Mucchino, Claudio; Bussolati, Ovidio; Franchi-Gazzola, Renata; Marchiò, Luciano (27 April 2011). "Copper Binding Agents Acting as Copper Ionophores Lead to Caspase Inhibition and Paraptotic Cell Death in Human Cancer Cells". Journal of the American Chemical Society. 133 (16): 6235–6242. doi:10.1021/ja109413c. PMID21452832.
^Chemistry of the elements (2nd ed.). Oxford: Butterworth-Heinemann. 1997. ISBN978-0-7506-3365-9.
^Steinrauf, L. K.; Hamilton, J. A.; Sabesan, M. N. (1982). "Crystal structure of valinomycin-sodium picrate. Anion effects on valinomycin-cation complexes". Journal of the American Chemical Society. 104 (15): 4085–4091. doi:10.1021/ja00379a008.
^Constable, Peter D.; Hinchcliff, Kenneth W.; Done, Stanley H.; Gruenberg, Walter (22 December 2016). "Chapter 66: Practical Antimicrobial Therapeutics". Veterinary medicine: a textbook of the diseases of cattle, horses, sheep, pigs and goats (Edition 11 ed.). St. Louis, Mo. ISBN978-0-7020-5246-0.{{cite book}}: CS1 maint: location missing publisher (link)
^Momose, Yuko; Maeda-Yamamoto, Mari; Nabetani, Hiroshi (17 August 2016). "Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans". International Journal of Food Sciences and Nutrition. 67 (6): 606–613. doi:10.1080/09637486.2016.1196655. PMID27324590. S2CID39704366.
^"Flavonoids". Linus Pauling Institute. 28 April 2014.
^TSAI, WEN-PO; NARA, PETER L.; KUNG, HSIANG-FU; OROSZLAN, STEPHEN (April 1990). "Inhibition of Human Immunodeficiency Virus Infectivity by Chloroquine". AIDS Research and Human Retroviruses. 6 (4): 481–489. doi:10.1089/aid.1990.6.481. PMID1692728.
^Romanelli, Frank; Smith, Kelly; Hoven, Ardis (1 August 2004). "Chloroquine and Hydroxychloroquine as Inhibitors of Human Immunodeficiency Virus (HIV-1) Activity". Current Pharmaceutical Design. 10 (21): 2643–2648. doi:10.2174/1381612043383791. PMID15320751.
^Lutz, Susanne; Hippe, Hans-Jörg; Niroomand, Feraydoon; Wieland, Thomas (2004). "Nucleoside Diphosphate Kinase–Mediated Activation of Heterotrimeric G Proteins". Regulators of G-Protein Signaling, Part B. Methods in Enzymology. Vol. 390. pp. 403–418. doi:10.1016/S0076-6879(04)90025-0. ISBN978-0-12-182795-3. PMID15488191.
^Leitgeb, Balázs; Szekeres, András; Manczinger, László; Vágvölgyi, Csaba; Kredics, László (June 2007). "The History of Alamethicin: A Review of the Most Extensively Studied Peptaibol". Chemistry & Biodiversity. 4 (6): 1027–1051. doi:10.1002/cbdv.200790095. PMID17589875.
^Logrieco, Antonio; Moretti, Antonio; Ritieni, Alberto; Caiaffa, Maria F.; Macchia, Luigi (2002). "Beauvericin: Chemistry, Biology and Significance". Advances in Microbial Toxin Research and Its Biotechnological Exploitation. pp. 23–30. doi:10.1007/978-1-4757-4439-2_2. ISBN978-1-4419-3384-3.
^Raatschen, Nadja; Wenzel, Michaela; Leichert, Lars Ingo Ole; Düchting, Petra; Krämer, Ute; Bandow, Julia Elisabeth (2013). "Extracting iron and manganese from bacteria with ionophores—A mechanism against competitors characterized by increased potency in environments low in micronutrients". Proteomics. 13 (8): 1358–1370. doi:10.1002/pmic.201200556. PMID23412951. S2CID24899763.
^Aggett, P.J.; Delves, H.T.; Harries, J.T.; Bangham, A.D. (March 1979). "The possible role of Diodoquin as a zinc ionophore in the treatment of acrodermatitis enteropathica". Biochemical and Biophysical Research Communications. 87 (2): 513–517. doi:10.1016/0006-291X(79)91825-4. PMID375935.
^Ovchinnikov, Yu. A.; Ivanov, V. T.; Evstratov, A. V.; Mikhaleva, I. I.; Bystrov, V. F.; Portnova, S. L.; Balashova, T. A.; Meshcheryakova, E. N.; Tulchinsky, V. M. (12 January 2009). "The Enniatin Ionophores. Conformation and Ion Binding Properties". International Journal of Peptide and Protein Research. 6 (6): 465–498. doi:10.1111/j.1399-3011.1974.tb02407.x. PMID4455641.
^Dabbagh-Bazarbachi, Husam; Clergeaud, Gael; Quesada, Isabel M.; Ortiz, Mayreli; O'Sullivan, Ciara K.; Fernández-Larrea, Juan B. (13 August 2014). "Zinc Ionophore Activity of Quercetin and Epigallocatechin-gallate: From Hepa 1-6 Cells to a Liposome Model". Journal of Agricultural and Food Chemistry. 62 (32): 8085–8093. doi:10.1021/jf5014633. PMID25050823.
^Toeplitz, Barbara K.; Cohen, Allen I.; Funke, Phillip T.; Parker, William L.; Gougoutas, Jack Z. (1 June 1979). "Structure of ionomycin - a novel diacidic polyether antibiotic having high affinity for calcium ions". Journal of the American Chemical Society. 101 (12): 3344–3353. doi:10.1021/ja00506a035.
^Gräfe, U.; Reinhardt, G.; Miosga, N. (1989). "Monovalent cation specificity of passive transport mediated by laidlomycin and 26-deoxylaidlomycin". Journal of Basic Microbiology. 29 (6): 391–394. doi:10.1002/jobm.3620290620. PMID2614677. S2CID38193390.
^Antonenko, Yuri N.; Yaguzhinsky, Lev S. (18 February 1988). "The ion selectivity of nonelectrogenic ionophores measured on a bilayer lipid membrane: nigericin, monensin, A23187 and lasalocid A". Biochimica et Biophysica Acta (BBA) - Biomembranes. 938 (2): 125–130. doi:10.1016/0005-2736(88)90151-4. PMID19927398.
^Huczyński, Adam; Ratajczak-Sitarz, Małgorzata; Katrusiak, Andrzej; Brzezinski, Bogumil (15 December 2007). "Molecular structure of the 1:1 inclusion complex of monensin A lithium salt with acetonitrile". Journal of Molecular Structure. 871 (1): 92–97. Bibcode:2007JMoSt.871...92H. doi:10.1016/j.molstruc.2006.07.046.
^Pinkerton, Mary; Steinrauf, L. K. (14 May 1970). "Molecular structure of monovalent metal cation complexes of monensin". Journal of Molecular Biology. 49 (3): 533–546. doi:10.1016/0022-2836(70)90279-2. PMID5453344.
^Marrone, Tami J.; Merz, Kenneth M. (September 1992). "Molecular recognition of potassium ion by the naturally occurring antibiotic ionophore nonactin". Journal of the American Chemical Society. 114 (19): 7542–7549. doi:10.1021/ja00045a030.
^Makrlík, Emanuel; Toman, Petr; Vaňura, Petr (April 2014). "Complexation of the thallium cation with nonactin: an experimental and theoretical study". Monatshefte für Chemie - Chemical Monthly. 145 (4): 551–555. doi:10.1007/s00706-014-1153-5. S2CID95393648.
^Bohlmann, Lisa; De Oliveira, David M. P.; El-Deeb, Ibrahim M.; Brazel, Erin B.; Harbison-Price, Nichaela; Ong, Cheryl-lynn Y.; Rivera-Hernandez, Tania; Ferguson, Scott A.; Cork, Amanda J.; Phan, Minh-Duy; Soderholm, Amelia T.; Davies, Mark R.; Nimmo, Graeme R.; Dougan, Gordon; Schembri, Mark A.; Cook, Gregory M.; McEwan, Alastair G.; von Itzstein, Mark; McDevitt, Christopher A.; Walker, Mark J. (11 December 2018). "Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance". mBio. 9 (6): e02391–18, /mbio/9/6/mBio.02391–18.atom. doi:10.1128/mBio.02391-18. PMC6299484. PMID30538186.
^Tardito, Saverio; Bassanetti, Irene; Bignardi, Chiara; Elviri, Lisa; Tegoni, Matteo; Mucchino, Claudio; Bussolati, Ovidio; Franchi-Gazzola, Renata; Marchiò, Luciano (27 April 2011). "Copper Binding Agents Acting as Copper Ionophores Lead to Caspase Inhibition and Paraptotic Cell Death in Human Cancer Cells". Journal of the American Chemical Society. 133 (16): 6235–6242. doi:10.1021/ja109413c. PMID21452832.
^Dabbagh-Bazarbachi, Husam; Clergeaud, Gael; Quesada, Isabel M.; Ortiz, Mayreli; O'Sullivan, Ciara K.; Fernández-Larrea, Juan B. (13 August 2014). "Zinc Ionophore Activity of Quercetin and Epigallocatechin-gallate: From Hepa 1-6 Cells to a Liposome Model". Journal of Agricultural and Food Chemistry. 62 (32): 8085–8093. doi:10.1021/jf5014633. PMID25050823.